Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants
Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investiga...
Uložené v:
| Vydané v: | PLoS medicine Ročník 17; číslo 7; s. e1003178 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Public Library of Science
23.07.2020
Public Library of Science (PLoS) |
| Predmet: | |
| ISSN: | 1549-1676, 1549-1277, 1549-1676 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers.
We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 × 10-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 × 10-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 × 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 × 10-5), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 × 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 × 10-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers.
Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. |
|---|---|
| AbstractList | Background
Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers.
Methods and findings
We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p -value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59–2.03; p = 2.26 × 10 −21 ) and UK Biobank (OR 2.26; 95% CI 1.92–2.65; p = 1.17 × 10 −22 ). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34–2.49; p = 1.31 × 10 −4 ), cervix (OR 1.55; 95% CI 1.27–1.88; p = 1.24 × 10 −5 ), and bladder (OR 1.40; 95% CI 1.92–2.65; p = 9.40 × 10 −5 ) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13–1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05–2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83–0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80–1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer ( n = 75,037 cases; OR 0.95; 95% CI 0.84–1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41–2.68; p = 4.68 × 10 −5 ) but not in UK Biobank (OR 1.12; 95% CI 0.65–1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers.
Conclusions
Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers. We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 x 10.sup.-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 x 10.sup.-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 x 10.sup.-4 ), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 x 10.sup.-5 ), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 x 10.sup.-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 x 10.sup.-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers. Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. In a mendelian randomization study, Susanna Larsson and colleagues identify genetic factors contributing to relationships between smoking and alcohol consumption and risk of overall and site-specific cancers among individuals in the UK Biobank and several international genome-wide association studies consortia. Background Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers. Methods and findings We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59–2.03; p = 2.26 × 10−21) and UK Biobank (OR 2.26; 95% CI 1.92–2.65; p = 1.17 × 10−22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34–2.49; p = 1.31 × 10−4), cervix (OR 1.55; 95% CI 1.27–1.88; p = 1.24 × 10−5), and bladder (OR 1.40; 95% CI 1.92–2.65; p = 9.40 × 10−5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13–1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05–2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83–0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80–1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84–1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41–2.68; p = 4.68 × 10−5) but not in UK Biobank (OR 1.12; 95% CI 0.65–1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers. Conclusions Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. Background Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers. Methods and findings We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 x 10.sup.-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 x 10.sup.-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 x 10.sup.-4 ), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 x 10.sup.-5 ), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 x 10.sup.-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 x 10.sup.-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers. Conclusions Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. Background Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers. Methods and findings We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59–2.03; p = 2.26 × 10−21) and UK Biobank (OR 2.26; 95% CI 1.92–2.65; p = 1.17 × 10−22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34–2.49; p = 1.31 × 10−4), cervix (OR 1.55; 95% CI 1.27–1.88; p = 1.24 × 10−5), and bladder (OR 1.40; 95% CI 1.92–2.65; p = 9.40 × 10−5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13–1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05–2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83–0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80–1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84–1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41–2.68; p = 4.68 × 10−5) but not in UK Biobank (OR 1.12; 95% CI 0.65–1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers. Conclusions Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. BackgroundSmoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers.Methods and findingsWe used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 × 10-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 × 10-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 × 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 × 10-5), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 × 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 × 10-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers.ConclusionsOur findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers. We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 × 10-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 × 10-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 × 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 × 10-5), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 × 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 × 10-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers. Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers.BACKGROUNDSmoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol consumption has been inconsistently associated with cancer risk in observational studies. This mendelian randomisation (MR) study sought to investigate associations in support of a causal relationship between smoking and alcohol consumption and 19 site-specific cancers.We used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 × 10-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 × 10-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 × 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 × 10-5), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 × 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 × 10-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers.METHODS AND FINDINGSWe used summary-level data for genetic variants associated with smoking initiation (ever smoked regularly) and alcohol consumption, and the corresponding associations with lung, breast, ovarian, and prostate cancer from genome-wide association studies consortia, including participants of European ancestry. We additionally estimated genetic associations with 19 site-specific cancers among 367,643 individuals of European descent in UK Biobank who were 37 to 73 years of age when recruited from 2006 to 2010. Associations were considered statistically significant at a Bonferroni corrected p-value below 0.0013. Genetic predisposition to smoking initiation was associated with statistically significant higher odds of lung cancer in the International Lung Cancer Consortium (odds ratio [OR] 1.80; 95% confidence interval [CI] 1.59-2.03; p = 2.26 × 10-21) and UK Biobank (OR 2.26; 95% CI 1.92-2.65; p = 1.17 × 10-22). Additionally, genetic predisposition to smoking was associated with statistically significant higher odds of cancer of the oesophagus (OR 1.83; 95% CI 1.34-2.49; p = 1.31 × 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 × 10-5), and bladder (OR 1.40; 95% CI 1.92-2.65; p = 9.40 × 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95% CI 1.13-1.74; p = 0.002) and stomach cancer (OR 1.46; 95% CI 1.05-2.03; p = 0.024). In contrast, there was an inverse association between genetic predisposition to smoking and prostate cancer in the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associations did not reach statistical significance. We found no statistically significant association between genetically predicted alcohol consumption and overall cancer (n = 75,037 cases; OR 0.95; 95% CI 0.84-1.07; p = 0.376). Genetically predicted alcohol consumption was statistically significantly associated with lung cancer in the International Lung Cancer Consortium (OR 1.94; 95% CI 1.41-2.68; p = 4.68 × 10-5) but not in UK Biobank (OR 1.12; 95% CI 0.65-1.93; p = 0.686). There was no statistically significant association between alcohol consumption and any other site-specific cancer. The main limitation of this study is that precision was low in some analyses, particularly for analyses of alcohol consumption and site-specific cancers.Our findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk.CONCLUSIONSOur findings support the well-established relationship between smoking and lung cancer and suggest that smoking may also be a risk factor for cancer of the head and neck, oesophagus, stomach, cervix, and bladder. We found no evidence supporting a relationship between alcohol consumption and overall or site-specific cancer risk. |
| Audience | Academic |
| Author | Mason, Amy M. Burgess, Stephen Kar, Siddhartha Vithayathil, Mathew Larsson, Susanna C. Carter, Paul Michaëlsson, Karl |
| AuthorAffiliation | 3 Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom University of Ioannina Medical School, GREECE 2 Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden 8 MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom 4 MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom 7 National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom 1 Department of Surgical Sciences, Uppsala University, Uppsala, Sweden 5 MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom 6 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom |
| AuthorAffiliation_xml | – name: 1 Department of Surgical Sciences, Uppsala University, Uppsala, Sweden – name: 7 National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom – name: 5 MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom – name: 4 MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom – name: 8 MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom – name: 6 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom – name: 3 Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom – name: University of Ioannina Medical School, GREECE – name: 2 Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden |
| Author_xml | – sequence: 1 givenname: Susanna C. orcidid: 0000-0003-0118-0341 surname: Larsson fullname: Larsson, Susanna C. – sequence: 2 givenname: Paul surname: Carter fullname: Carter, Paul – sequence: 3 givenname: Siddhartha orcidid: 0000-0002-2314-1426 surname: Kar fullname: Kar, Siddhartha – sequence: 4 givenname: Mathew orcidid: 0000-0002-1457-4385 surname: Vithayathil fullname: Vithayathil, Mathew – sequence: 5 givenname: Amy M. orcidid: 0000-0002-8019-0777 surname: Mason fullname: Mason, Amy M. – sequence: 6 givenname: Karl surname: Michaëlsson fullname: Michaëlsson, Karl – sequence: 7 givenname: Stephen orcidid: 0000-0001-5365-8760 surname: Burgess fullname: Burgess, Stephen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32701947$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-421087$$DView record from Swedish Publication Index (Uppsala universitet) http://kipublications.ki.se/Default.aspx?queryparsed=id:144394105$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNqVlNtu1DAQhiNURA_wBggiISGQuotPObgXSEs5VVRUorS3lmM7u946dogToG_AY-PsZmFTFQRKJFvjb36PZzzej3assyqKHkIwhTiDL5auayw307pScgoBwDDL70R7MCF0AtMs3dma70b73i8BQBRQcC_axSgDkJJsL_pxXrkrbeeHMTfCLZyJhbO-q-pWOxuMVsaCW6Gao3gWV8pKZTS3cRMWXKU977HYt528jrWNLz7Er7QruL1aeWrbqhBjz3ATz5VVrRarDVzTah7XPAxC19y2_n50t-TGqwfDeBBdvH3z-fj95PTs3cnx7HQickzbSVHKjEsAikISTghKORWpTCEpREYxgSUvAQEgkTDHCaQoRUpiShFAEIuiUPggerzWrY3zbEiiZ4hgQmiGchSIkzUhHV-yutEVb66Z45qtDK6Zs1XcRjGS8zxNgOBQhlgoL5REGUkTTERBFMqC1mSt5b-puitGaoPpKsyCUkoT2POHf-Rf68vZaveuYwRBkPf4y-EwXRGugVC2bbgZeY1XrF6wufvKMpyFHwSBZ4NA4750yrcsFFUoY7hVruvTEg4BaIZhQJ_cQG9P3kDNeciPtqUL-4pelM1SjGgCUpD_TsuI6i9ICDJc81IH84if3sKHT6pKi1sdno8cAtOq7-2cd96zk_NP_8F-_Hf27HLMPt1iF4qbduGd6fp28GPw0XYVf5Vv06UBOFoDonHeN6pkQrertgpp0IZBwPonYVMQ1j8JbHgSgjO54bzR_6vbT9HLZVw |
| CitedBy_id | crossref_primary_10_1016_j_parkreldis_2022_02_013 crossref_primary_10_1371_journal_pone_0269742 crossref_primary_10_1002_ijc_33963 crossref_primary_10_1002_ijc_34656 crossref_primary_10_1186_s12920_023_01782_7 crossref_primary_10_1002_cam4_5498 crossref_primary_10_4251_wjgo_v16_i7_3055 crossref_primary_10_1210_clinem_dgab713 crossref_primary_10_1093_mr_roae084 crossref_primary_10_1002_ijc_35187 crossref_primary_10_1186_s12957_023_03064_z crossref_primary_10_1038_s41598_024_80160_4 crossref_primary_10_1007_s12672_025_02226_7 crossref_primary_10_1016_j_eururo_2022_03_033 crossref_primary_10_3389_fpubh_2023_1022367 crossref_primary_10_1016_j_annepidem_2023_06_002 crossref_primary_10_3389_fpubh_2023_1321457 crossref_primary_10_1016_j_clnu_2020_11_004 crossref_primary_10_1016_j_athplu_2025_04_002 crossref_primary_10_1016_j_clnu_2022_07_040 crossref_primary_10_1038_s41598_021_83801_0 crossref_primary_10_1016_j_ebiom_2022_103895 crossref_primary_10_3389_fonc_2021_681396 crossref_primary_10_1017_S0007114522003464 crossref_primary_10_1038_s41562_023_01624_7 crossref_primary_10_1038_s41467_023_41231_8 crossref_primary_10_1038_s41591_023_02383_8 crossref_primary_10_1186_s12916_020_01839_9 crossref_primary_10_3390_cancers16173005 crossref_primary_10_1186_s12916_022_02246_y crossref_primary_10_1186_s12890_022_02297_0 crossref_primary_10_1038_s41416_023_02397_6 crossref_primary_10_1161_JAHA_120_020187 crossref_primary_10_1038_s41591_024_03483_9 crossref_primary_10_1097_MOL_0000000000000721 crossref_primary_10_1371_journal_pmed_1004362 crossref_primary_10_1002_pros_24646 crossref_primary_10_1038_s41598_022_05832_5 crossref_primary_10_18332_tid_189199 crossref_primary_10_3389_fonc_2023_1108633 crossref_primary_10_3389_fgene_2022_868408 crossref_primary_10_1002_cam4_6406 crossref_primary_10_1038_s41598_025_14119_4 crossref_primary_10_3389_fimmu_2024_1404812 crossref_primary_10_3390_epidemiologia5030043 crossref_primary_10_1016_j_neuroscience_2024_10_007 crossref_primary_10_1186_s12920_022_01367_w crossref_primary_10_1016_j_thromres_2024_109207 crossref_primary_10_3390_cancers16040749 crossref_primary_10_1186_s40959_021_00094_y crossref_primary_10_1007_s00432_023_05518_z crossref_primary_10_1016_j_ebiom_2022_104154 crossref_primary_10_1186_s12916_020_01797_2 crossref_primary_10_1002_ijc_33917 crossref_primary_10_3390_nu13093173 crossref_primary_10_1186_s12876_024_03576_2 crossref_primary_10_3390_ma14133706 crossref_primary_10_1038_s41416_021_01432_8 crossref_primary_10_1007_s00432_023_04606_4 crossref_primary_10_3892_or_2024_8765 crossref_primary_10_3390_clinpract14030091 crossref_primary_10_1158_1055_9965_EPI_24_1440 crossref_primary_10_1038_s41598_023_50055_x crossref_primary_10_3390_cancers15184525 crossref_primary_10_1016_j_chest_2024_06_3811 crossref_primary_10_1097_MD_0000000000040702 crossref_primary_10_3389_fendo_2025_1541744 crossref_primary_10_3390_cancers17020285 crossref_primary_10_1016_j_heliyon_2024_e32063 crossref_primary_10_1038_s41598_024_53926_z crossref_primary_10_1186_s13075_023_03157_w crossref_primary_10_1186_s12885_023_11662_z crossref_primary_10_1111_add_15593 crossref_primary_10_3389_fonc_2024_1373380 crossref_primary_10_3390_biology12050673 crossref_primary_10_3389_fonc_2022_829248 crossref_primary_10_1155_2021_1893882 crossref_primary_10_3390_cancers14041019 crossref_primary_10_3389_fonc_2024_1424812 crossref_primary_10_1038_s41598_024_73333_8 crossref_primary_10_1186_s12889_024_19944_2 crossref_primary_10_3389_fgene_2021_742718 crossref_primary_10_1002_ijc_34228 crossref_primary_10_3390_nu16060800 crossref_primary_10_1002_cam4_4015 crossref_primary_10_1002_ijc_33538 crossref_primary_10_1016_j_scitotenv_2022_159890 crossref_primary_10_1038_s41598_023_44144_0 crossref_primary_10_1038_s42003_021_02685_y crossref_primary_10_1007_s10654_022_00879_0 crossref_primary_10_1016_j_ebiom_2024_105234 crossref_primary_10_1136_bmjopen_2020_046329 crossref_primary_10_1038_s41467_020_19822_6 crossref_primary_10_1093_ije_dyad090 crossref_primary_10_3389_fonc_2024_1371309 crossref_primary_10_1038_s41571_024_00881_3 crossref_primary_10_24060_2076_3093_2023_13_3_221_228 crossref_primary_10_1002_bco2_70086 crossref_primary_10_1002_ijc_35449 crossref_primary_10_1111_cen_14966 crossref_primary_10_1002_cam4_5233 crossref_primary_10_1016_j_canep_2021_102055 crossref_primary_10_3390_cells12232724 crossref_primary_10_7554_eLife_84051 crossref_primary_10_1016_j_prnil_2024_03_003 crossref_primary_10_3390_jcm11102925 crossref_primary_10_1186_s12916_024_03305_2 crossref_primary_10_1177_10732748251341523 crossref_primary_10_3390_nu16101517 crossref_primary_10_1002_ijc_34645 crossref_primary_10_1183_13993003_01399_2021 crossref_primary_10_1080_07853890_2025_2500693 crossref_primary_10_7554_eLife_82608 crossref_primary_10_1038_s41598_024_54259_7 crossref_primary_10_1007_s00289_024_05298_7 crossref_primary_10_1080_1040841X_2023_2247493 crossref_primary_10_1002_ijc_35210 crossref_primary_10_1186_s13019_024_02625_x crossref_primary_10_2196_44695 crossref_primary_10_1038_s41598_023_43926_w crossref_primary_10_1038_s41467_024_52129_4 crossref_primary_10_1136_jnnp_2023_332293 |
| Cites_doi | 10.1038/ng.3002 10.2105/AJPH.2008.150508 10.1158/1055-9965.EPI-05-0196 10.1093/annonc/mds337 10.1093/ije/dyu005 10.1002/ijc.32377 10.1038/bjc.2014.579 10.1001/jamainternmed.2016.7511 10.1371/journal.pmed.1001779 10.1038/s41588-018-0142-8 10.1093/ije/dyy195 10.1016/S0140-6736(12)61720-6 10.1158/1055-9965.EPI-08-0462 10.1007/s00223-019-00606-0 10.1158/1055-9965.EPI-09-0252 10.1093/ije/dyx034 10.1038/s41588-018-0099-7 10.1002/ijc.30436 10.1002/ana.25534 10.1002/gepi.21998 10.1093/jnci/djz103 10.1093/jnci/djn514 10.1038/s41598-019-56014-9 10.1111/j.1753-4887.2008.00076.x 10.1038/s41588-018-0307-5 10.1093/jnci/djk181 10.1097/EDE.0000000000000559 10.1038/bjc.2012.520 10.1038/nature24284 10.1093/ije/dyv156 10.1002/ajh.23744 10.1038/s41467-019-14156-4 10.1111/j.1463-1318.2010.02530.x 10.1016/S0140-6736(18)31310-2 10.7554/eLife.34408 10.1016/S1470-2045(09)70326-2 10.1038/ng.3826 10.1093/bioinformatics/btv402 10.1080/10408390701761845 10.1016/j.canep.2014.06.001 10.1214/11-STS360 10.1002/ijc.23033 10.1136/bmj.d636 10.1093/aje/kwr026 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 Public Library of Science 2020 Larsson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 Larsson et al 2020 Larsson et al |
| Copyright_xml | – notice: COPYRIGHT 2020 Public Library of Science – notice: 2020 Larsson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 Larsson et al 2020 Larsson et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ACNBI ADTPV AOWAS D8T DF2 ZZAVC DOA CZK |
| DOI | 10.1371/journal.pmed.1003178 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text DOAJ Directory of Open Access Journals PLoS Medicine |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| DocumentTitleAlternate | Smoking, alcohol, and cancer |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2434497282 oai_doaj_org_article_48a8650ca1d4429abed2746534cb4e27 oai_swepub_ki_se_469517 oai_DiVA_org_uu_421087 PMC7377370 A632950608 32701947 10_1371_journal_pmed_1003178 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom United Kingdom--UK Sweden |
| GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK – name: Sweden |
| GrantInformation_xml | – fundername: Wellcome Trust grantid: 204623/Z/16/Z – fundername: Department of Health – fundername: Medical Research Council grantid: MC_UU_00002/7 – fundername: Cancer Research UK grantid: C18281/A19169 – fundername: Medical Research Council grantid: MC_PC_17228 – fundername: Medical Research Council grantid: MC_QA137853 – fundername: ; – fundername: ; grantid: 2018-00123 – fundername: ; grantid: 20190247 – fundername: ; grantid: C18281/A19169 – fundername: ; grantid: 204623/Z/16/Z – fundername: ; grantid: 2019-00977 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFFHD AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBTPI BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ADRAZ ADXHL ALIPV CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM ACNBI ADTPV AOWAS D8T DF2 ZZAVC AAPBV ABPTK BCGST CZK ICW M~E |
| ID | FETCH-LOGICAL-c839t-bfd7ad00bbd4a4426a9c6d614bc79341faf04005d183519262ed39920213cbbe3 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 136 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000559725400006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Sun Oct 01 00:20:29 EDT 2023 Mon Nov 10 04:30:50 EST 2025 Tue Nov 25 03:31:53 EST 2025 Tue Nov 04 16:38:21 EST 2025 Tue Nov 04 01:50:12 EST 2025 Wed Oct 01 14:19:39 EDT 2025 Sat Nov 29 14:32:43 EST 2025 Tue Nov 11 07:44:00 EST 2025 Sat Nov 29 11:10:35 EST 2025 Tue Nov 04 18:00:12 EST 2025 Thu Nov 13 14:22:21 EST 2025 Thu Nov 13 14:38:54 EST 2025 Thu Nov 13 14:29:52 EST 2025 Thu May 22 21:04:59 EDT 2025 Mon Jul 21 06:06:38 EDT 2025 Tue Nov 18 21:13:44 EST 2025 Sat Nov 29 05:34:00 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c839t-bfd7ad00bbd4a4426a9c6d614bc79341faf04005d183519262ed39920213cbbe3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 I have read the journal's policy and the authors of this manuscript have the following competing interests: SB is a paid statistical consultant on PLOS Medicine's statistical board. |
| ORCID | 0000-0001-5365-8760 0000-0002-8019-0777 0000-0002-2314-1426 0000-0002-1457-4385 0000-0003-0118-0341 |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pmed.1003178 |
| PMID | 32701947 |
| PQID | 2434497282 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2434497282 doaj_primary_oai_doaj_org_article_48a8650ca1d4429abed2746534cb4e27 swepub_primary_oai_swepub_ki_se_469517 swepub_primary_oai_DiVA_org_uu_421087 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7377370 proquest_miscellaneous_2427309731 proquest_journals_2434497282 gale_infotracmisc_A632950608 gale_infotracgeneralonefile_A632950608 gale_infotracacademiconefile_A632950608 gale_incontextgauss_ISR_A632950608 gale_incontextgauss_ISN_A632950608 gale_incontextgauss_IOV_A632950608 gale_healthsolutions_A632950608 pubmed_primary_32701947 crossref_citationtrail_10_1371_journal_pmed_1003178 crossref_primary_10_1371_journal_pmed_1003178 |
| PublicationCentury | 2000 |
| PublicationDate | 20200723 |
| PublicationDateYYYYMMDD | 2020-07-23 |
| PublicationDate_xml | – month: 7 year: 2020 text: 20200723 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2020 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | K Pirie (pmed.1003178.ref005) 2013; 381 TM Palmer (pmed.1003178.ref042) 2011; 173 K Michailidou (pmed.1003178.ref017) 2017; 551 S Boccia (pmed.1003178.ref036) 2009; 18 S Burgess (pmed.1003178.ref023) 2017; 28 MS Fernandez-Panchon (pmed.1003178.ref035) 2008; 48 EE McGee (pmed.1003178.ref008) 2020; 111 JE Lee (pmed.1003178.ref011) 2007; 99 W Spiller (pmed.1003178.ref026) 2019; 48 S Gandini (pmed.1003178.ref004) 2008; 122 G Hemani (pmed.1003178.ref020) 2018; 7 Collaborators GBDA (pmed.1003178.ref001) 2018; 392 S McNabb (pmed.1003178.ref010); 146 Y Wang (pmed.1003178.ref016) 2014; 46 SE Brien (pmed.1003178.ref033) 2011; 342 M Verbanck (pmed.1003178.ref025) 2018; 50 C Brunner (pmed.1003178.ref040) 2017; 140 SC Larsson (pmed.1003178.ref044) 2020 J Wang (pmed.1003178.ref038) 2011; 13 M Inoue-Choi (pmed.1003178.ref002) 2017; 177 OO Yavorska (pmed.1003178.ref027) 2017; 46 SC Larsson (pmed.1003178.ref045) 2019; 86 S Burgess (pmed.1003178.ref024) 2020; 11 V Bagnardi (pmed.1003178.ref012) 2015; 112 M Rota (pmed.1003178.ref039) 2014; 38 S Yuan (pmed.1003178.ref046) 2019; 9 C Sudlow (pmed.1003178.ref021) 2015; 12 CM Phelan (pmed.1003178.ref018) 2017; 49 S Vansteelandt (pmed.1003178.ref043) 2011; 26 V Bagnardi (pmed.1003178.ref014) 2013; 24 S Rohrmann (pmed.1003178.ref031) 2013; 108 NE Allen (pmed.1003178.ref009) 2009; 101 S Burgess (pmed.1003178.ref041) 2016; 40 JL Watters (pmed.1003178.ref032) 2009; 18 SJ Lewis (pmed.1003178.ref037) 2005; 14 S Jung (pmed.1003178.ref013) 2016; 45 S Yuan (pmed.1003178.ref047) 2019; 105 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (pmed.1003178.ref006) 2004; 83 B Secretan (pmed.1003178.ref007) 2009; 10 M Liu (pmed.1003178.ref015) 2019; 51 World Health Organization (pmed.1003178.ref003) 2012 FR Schumacher (pmed.1003178.ref019) 2018; 50 MJ Machiela (pmed.1003178.ref022) 2015; 31 M Huncharek (pmed.1003178.ref030) 2010; 100 S Fircanis (pmed.1003178.ref029) 2014; 89 S Burgess (pmed.1003178.ref028) 2014; 43 CC Udenigwe (pmed.1003178.ref034) 2008; 66 |
| References_xml | – volume: 46 start-page: 736 year: 2014 ident: pmed.1003178.ref016 article-title: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer publication-title: Nat Genet doi: 10.1038/ng.3002 – volume: 100 start-page: 693 year: 2010 ident: pmed.1003178.ref030 article-title: Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies publication-title: Am J Public Health doi: 10.2105/AJPH.2008.150508 – volume: 14 start-page: 1967 year: 2005 ident: pmed.1003178.ref037 article-title: Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0196 – volume: 24 start-page: 301 year: 2013 ident: pmed.1003178.ref014 article-title: Light alcohol drinking and cancer: a meta-analysis publication-title: Ann Oncol doi: 10.1093/annonc/mds337 – volume: 43 start-page: 922 year: 2014 ident: pmed.1003178.ref028 article-title: Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome publication-title: Int J Epidemiol doi: 10.1093/ije/dyu005 – volume: 146 start-page: 861 ident: pmed.1003178.ref010 article-title: Meta-analysis of 16 studies of the association of alcohol with colorectal cancer publication-title: Int J Cancer doi: 10.1002/ijc.32377 – volume: 112 start-page: 580 year: 2015 ident: pmed.1003178.ref012 article-title: Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis publication-title: Br J Cancer doi: 10.1038/bjc.2014.579 – volume: 177 start-page: 87 year: 2017 ident: pmed.1003178.ref002 article-title: Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP Diet and Health Study publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2016.7511 – volume: 12 start-page: e1001779 year: 2015 ident: pmed.1003178.ref021 article-title: UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age publication-title: PLoS Med doi: 10.1371/journal.pmed.1001779 – volume: 50 start-page: 928 year: 2018 ident: pmed.1003178.ref019 article-title: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci publication-title: Nat Genet doi: 10.1038/s41588-018-0142-8 – volume: 48 start-page: 684 year: 2019 ident: pmed.1003178.ref026 article-title: Software application profile: mrrobust—a tool for performing two-sample summary Mendelian randomization analyses publication-title: Int J Epidemiol doi: 10.1093/ije/dyy195 – volume: 381 start-page: 133 year: 2013 ident: pmed.1003178.ref005 article-title: The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK publication-title: Lancet doi: 10.1016/S0140-6736(12)61720-6 – volume: 18 start-page: 248 year: 2009 ident: pmed.1003178.ref036 article-title: Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0462 – volume: 105 start-page: 582 year: 2019 ident: pmed.1003178.ref047 article-title: Associations of Smoking and Alcohol and Coffee Intake with Fracture and Bone Mineral Density: A Mendelian Randomization Study publication-title: Calcif Tissue Int doi: 10.1007/s00223-019-00606-0 – volume: 18 start-page: 2427 year: 2009 ident: pmed.1003178.ref032 article-title: Cigarette smoking and prostate cancer in a prospective US cohort study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-09-0252 – volume: 46 start-page: 1734 year: 2017 ident: pmed.1003178.ref027 article-title: MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data publication-title: Int J Epidemiol doi: 10.1093/ije/dyx034 – volume: 50 start-page: 693 year: 2018 ident: pmed.1003178.ref025 article-title: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases publication-title: Nat Genet doi: 10.1038/s41588-018-0099-7 – volume: 140 start-page: 75 year: 2017 ident: pmed.1003178.ref040 article-title: Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study publication-title: Int J Cancer doi: 10.1002/ijc.30436 – volume: 86 start-page: 468 year: 2019 ident: pmed.1003178.ref045 article-title: Smoking and stroke: a Mendelian randomization study publication-title: Ann Neurol doi: 10.1002/ana.25534 – volume: 40 start-page: 597 year: 2016 ident: pmed.1003178.ref041 article-title: Bias due to participant overlap in two-sample Mendelian randomization publication-title: Genet Epidemiol doi: 10.1002/gepi.21998 – volume: 111 start-page: 1263 year: 2020 ident: pmed.1003178.ref008 article-title: Smoking, alcohol, and biliary tract cancer risk: a Pooling Project of 26 prospective studies publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djz103 – volume: 101 start-page: 296 year: 2009 ident: pmed.1003178.ref009 article-title: Moderate alcohol intake and cancer incidence in women publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn514 – volume: 9 start-page: 19342 year: 2019 ident: pmed.1003178.ref046 article-title: A causal relationship between cigarette smoking and type 2 diabetes mellitus: A Mendelian randomization study publication-title: Sci Rep doi: 10.1038/s41598-019-56014-9 – volume: 66 start-page: 445 year: 2008 ident: pmed.1003178.ref034 article-title: Potential of resveratrol in anticancer and anti-inflammatory therapy publication-title: Nutr Rev doi: 10.1111/j.1753-4887.2008.00076.x – volume: 51 start-page: 237 year: 2019 ident: pmed.1003178.ref015 article-title: Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use publication-title: Nat Genet doi: 10.1038/s41588-018-0307-5 – volume: 99 start-page: 801 year: 2007 ident: pmed.1003178.ref011 article-title: Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djk181 – volume: 28 start-page: 30 year: 2017 ident: pmed.1003178.ref023 article-title: Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants publication-title: Epidemiology doi: 10.1097/EDE.0000000000000559 – volume: 108 start-page: 708 year: 2013 ident: pmed.1003178.ref031 article-title: Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition publication-title: Br J Cancer doi: 10.1038/bjc.2012.520 – volume: 551 start-page: 92 year: 2017 ident: pmed.1003178.ref017 article-title: Association analysis identifies 65 new breast cancer risk loci publication-title: Nature doi: 10.1038/nature24284 – volume: 83 start-page: 1 year: 2004 ident: pmed.1003178.ref006 article-title: Tobacco smoke and involuntary smoking publication-title: IARC Monogr Eval Carcinog Risks Hum – volume: 45 start-page: 916 year: 2016 ident: pmed.1003178.ref013 article-title: Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies publication-title: Int J Epidemiol doi: 10.1093/ije/dyv156 – volume: 89 start-page: E125 year: 2014 ident: pmed.1003178.ref029 article-title: The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies publication-title: Am J Hematol doi: 10.1002/ajh.23744 – year: 2020 ident: pmed.1003178.ref044 article-title: Genetic predisposition to smoking in relation to 14 cardiovascular diseases publication-title: Eur Heart J – volume: 11 start-page: 376 year: 2020 ident: pmed.1003178.ref024 article-title: A robust and efficient method for Mendelian randomization with hundreds of genetic variants publication-title: Nat Commun doi: 10.1038/s41467-019-14156-4 – volume: 13 start-page: e71 year: 2011 ident: pmed.1003178.ref038 article-title: Alcohol ingestion and colorectal neoplasia: a meta-analysis based on a Mendelian randomization approach publication-title: Colorectal Dis doi: 10.1111/j.1463-1318.2010.02530.x – volume: 392 start-page: 1015 year: 2018 ident: pmed.1003178.ref001 article-title: Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(18)31310-2 – volume: 7 year: 2018 ident: pmed.1003178.ref020 article-title: The MR-Base platform supports systematic causal inference across the human phenome publication-title: Elife doi: 10.7554/eLife.34408 – volume: 10 start-page: 1033 year: 2009 ident: pmed.1003178.ref007 article-title: A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70326-2 – volume: 49 start-page: 680 year: 2017 ident: pmed.1003178.ref018 article-title: Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer publication-title: Nat Genet doi: 10.1038/ng.3826 – volume: 31 start-page: 3555 year: 2015 ident: pmed.1003178.ref022 article-title: LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv402 – volume: 48 start-page: 649 year: 2008 ident: pmed.1003178.ref035 article-title: Antioxidant activity of phenolic compounds: from in vitro results to in vivo evidence publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408390701761845 – volume: 38 start-page: 339 year: 2014 ident: pmed.1003178.ref039 article-title: Alcohol drinking and risk of leukemia-a systematic review and meta-analysis of the dose-risk relation publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2014.06.001 – volume-title: WHO global report on mortality attributable to tobacco year: 2012 ident: pmed.1003178.ref003 – volume: 26 start-page: 403 year: 2011 ident: pmed.1003178.ref043 article-title: On instrumental variables estimation of causal odds ratios publication-title: Stat Sci doi: 10.1214/11-STS360 – volume: 122 start-page: 155 year: 2008 ident: pmed.1003178.ref004 article-title: Tobacco smoking and cancer: a meta-analysis publication-title: Int J Cancer doi: 10.1002/ijc.23033 – volume: 342 start-page: d636 year: 2011 ident: pmed.1003178.ref033 article-title: Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies publication-title: BMJ doi: 10.1136/bmj.d636 – volume: 173 start-page: 1392 year: 2011 ident: pmed.1003178.ref042 article-title: Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses publication-title: Am J Epidemiol doi: 10.1093/aje/kwr026 |
| SSID | ssj0029090 |
| Score | 2.6445315 |
| Snippet | Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers. Alcohol... Background Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers.... In a mendelian randomization study, Susanna Larsson and colleagues identify genetic factors contributing to relationships between smoking and alcohol... Background Smoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers.... BackgroundSmoking is a well-established cause of lung cancer and there is strong evidence that smoking also increases the risk of several other cancers.... |
| SourceID | plos doaj swepub pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1003178 |
| SubjectTerms | Addictive behaviors Alcohol Alcohol Drinking - genetics Alcohol use Analysis Biobanks Biological Specimen Banks Biology and Life Sciences Bladder cancer Breast cancer Cancer Cancer genetics Cancer research Cervix Colorectal cancer Consortia Drinking (Alcoholic beverages) Epidemiology Esophageal cancer Esophagus Female Gastric cancer Genetic aspects Genetic diversity Genetic Predisposition to Disease Genetic research Genome-Wide Association Study Genomes Genomics Head & neck cancer Head and neck cancer Health aspects Humans Inheritances Kidney cancer Lung cancer Male Medicine and Health Sciences Mendelian Randomization Analysis - methods Meta-analysis Methods Neoplasms - etiology Neoplasms - genetics Ovarian cancer Polymorphism, Single Nucleotide Primary care Prostate cancer Public health Research and Analysis Methods Risk factors Smoking Smoking - genetics Social Sciences Standard deviation Statistical analysis Stomach Studies United Kingdom White People - genetics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbQhBAviPsKAwyC8UJY4rhxwlsHTCBEQYxNe4t8y4i2JlXT8hv42Zxju9EiKm0PSJVa2Z9j1efiY-f4MyEvVSIFM0kVZcpmEU95HOWGmUgxWXBuRWELf9mEmE7zk5Pi-4WrvjAnzNMD-4Hb47nMIYrQMjEcfKdU1sBCKhunXCtumTtHDlHPejEVllpF7HZXkH8sSpgQ4dBcKpK9IKO3c5htMEcAJtB8MCk57v7eQ2_Nz9tuU_j5bxblgGvUzU8Ht8mtEFjSif9Dd8g129wlN76GV-f3yJ_DWYvb4m-o9LfiUu1OXzqXAYWNoRo1YPGOTugMN8ZxA4TCVGbaWcj5oY6MltYNPfpC92twBc2Za1lf3FekoJN4NNJ1ANF9LelchuztZtndJ0cHH3--_xSFaxgiDdHTMlKVEdLEsVKGS5BBJgudGZjWlQbj5kklK_QEYwPeAeJBljFrkO4WoodUK2XTB2SraRu7Teg4tpWwhawqlXMjdM5zkJCG73HFhM5GJF3LodSBoxyvyjgv3Ys3AWsVP5olSq8M0huRqG819xwdl-D3UcQ9Fhm2XQHoXRn0rrxM70bkGSpI6Y-r9n6inGQpK5C1Ebp54RDIstFgGs-pXHVd-fnb8RVAh9OrgH4MQK8DqGphzLQM5ytg5JHia4DcHSBPPcH5JuDOAAjapgfV22gc6zHuSga2zgsBq3houTaYzdXP-2p8KCb6NbZdIQbiaaSQSkbkobevXk4pw7sDOAy9GFjeQJDDmqb-5SjTRSrgE4_IK2-jgyYf6uOJk_1qVXKWxDn0sLsBF4rO4BfoRwZrE_Hof6jSY3KT4S5OLCKW7pCt5WJln5Dr-vey7hZPnWP7C_tKqVQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwELagQwgJ8TJeVhhgEIwvhCWOGyd8QR1sAiHKtDftW-TYTom2JqVp-Q38bO4cNxBRwSSkSqnsx4lin8_ny_k5Qp5ngRRMB7kXZSbyeMh9L9ZMexmTCedGJCZpkk2I0Sg-PU32ncOtdmGVS51oFbWuFPrItxnchycCdghvp988zBqFX1ddCo3LZA2ZyniPrO3sjvYP2i1X4lsvC_KQeQETwh2eC0Ww7cbq9RRWHYwVgIU07ixOlsO_1dS96XlVrzJD_4ym7HCO2nVq7-b_vuEtcsNZqHTYiNRtcsmU6-TqZ_cNfp1cbzx9tDnAdIf8OJxU6G9_RWWTbpcqe6zT6iIoLDVVKFqzN3RIJ-hxR88KhTVSVxMXTEQtyy0tSnr8ie4UoGPKM9uy-N1hSUHY8cylfQBsGwpJp9KFhZfz-i453ts9evfBc_kdPAVm2dzLci2k9v0s01xyMBVkoiIN9kKmQGvwIJc5qpiBBrUDhiaLmNHIowtmSaiyzIT3SK-sSrNB6MA3uTCJzPMs5lqomMcw5Aqug5wJFfVJuBzYVDnyc8zBcZ7aL3oCNkFN76YoDqkThz7x2lbThvzjH_gdlJkWi9TdtqCajVOnCVIeyxjMYiUDDe-cyMxoJpDljquMGyb65AlKXNqcg20VUDqMQpYgHSQ85plFIH1HifFBY7mo6_Tjl5MLgA5HFwEddEAvHSivoM-UdAc3oOeRO6yD3Oogxw1z-irgZgcI0qY61Rs425Z9XKe_pga0XE6e1dVP22q8KUYQlqZaIAYMdeSmCvrkfjNh23EKGSYl4ND1ojOVOwPZrSmLr5aLXYQCfn6fvGgmfafJ--JkaMd-sUg5C_wYnrC1AueKzuAfyEcEmx7x4O_v-ZBcY-j48YXHwk3Sm88W5hG5or7Pi3r22GnBn8fAvgo priority: 102 providerName: ProQuest |
| Title | Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32701947 https://www.proquest.com/docview/2434497282 https://www.proquest.com/docview/2427309731 https://pubmed.ncbi.nlm.nih.gov/PMC7377370 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-421087 http://kipublications.ki.se/Default.aspx?queryparsed=id:144394105 https://doaj.org/article/48a8650ca1d4429abed2746534cb4e27 http://dx.doi.org/10.1371/journal.pmed.1003178 |
| Volume | 17 |
| WOSCitedRecordID | wos000559725400006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1277 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1277 databaseCode: 7X7 dateStart: 20041001 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1277 databaseCode: BENPR dateStart: 20041001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1277 databaseCode: PIMPY dateStart: 20041001 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1277 databaseCode: FPL dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1tb9MwELbYhhAS4mW8rDCKQTC-EEgcN0741sEqJlipNjaVT5FjOyPallZLy2_gZ3PnuIFAJ4ZUtZX9uFHP5_Pd2X5MyPMskILpIPeizEQeD7nvxZppL2My4dyIxCT1ZRNiOIzH42T0K1D8YwU_FMEbJ9PXU5gdcE0fJrx4hayxMIpwC9dg9KkJsBI_8d3xuItatqYfy9Lf2OLV6emkWuZo_r1fssUqameiwa3__Q-3yU3nc9J-rSR3yBVTrpNre25VfZ3cqHN3tD6SdJf8ODibYAb9FZX1BbpU2YOa1rpAYampQmU5f0v79Axz6JgroTDr6cmZ2x5ELW8tLUp6-JFuF2A1yhPbsvg9BUlBffEUpX0ABAKFpFPpNnqXs-oeORzsfHn3wXM3NngKHK2Zl-VaSO37Waa55DD5y0RFGjyATIEd4EEuczQaPQ2GBFxHFjGjkRkXHI1QZZkJ75PVclKaDUJ7vsmFSWSeZzHXQsU8hlBWwWcvZ0JFHRIuOjJVjs4cb9U4Te0anYCwppZuikJPndA7xGtaTWs6j3_gt1FHGiyScdsC6N3Uje2UxzIGR1fJQMN_TmRmNMT6US_kKuOGiQ55ghqW1idbG5OS9qOQJUjwCI95ZhFIyFHijp9jOa-qdPfz0SVAB8PLgPZboJcOlE9AZkq6oxggeWQDayG3Wsjjmgt9GXCzBQRtU63qDRxdCxlXKQOzwBMBAT-0XIy45dVPm2r8UdwTWJrJHDHgeiPbVNAhD-oB2vRTyPCaAQ6iF62h2-rIdk1ZfLPs6iIU8PI75EU9yFtN3hdHfdv383nKWeDH8IStJThXdALfQD8iCGPEw4tF8IhcZ5jG8YXHwk2yOjufm8fkqvo-K6rzLlkRY2Hf4y5Z294Zjva7NnXUtdYPyka7e6OvPwHDUK8V |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1tb9MwELbGQICEeBkvKwxmEBtfCEscL06QEOoY06ZtHWIv2rfg2E6JtialaUH8A34Nv5E7J-2IqGBf9gGpUqr4nCjn853PvnuOkOeJJwXTXuoEiQkc7nPXCTXTTsJkxLkRkYmqYhOi0wmPj6MPM-TnOBcGwyrHOtEqal0o3CNfYfAcHgnwEN72vzhYNQpPV8clNCqx2Dbfv4HLVr7ZWofxXWJs4_3Bu02nrirgKFgMDJ0k1UJq100SzSUHAyUjFWiwUokCWeVeKlMU7FUNwg7LGxYwoxG9FYyhr5LE-PDcS-Qy6HGBIWTi-MzBi1y7p4OoZ47HhKhT9XzhrdSS8aoPNg4jE8Bshw1TaCsGTOzCbP-0KKctev-M3WwgnFqruHHrf-PnbXKzXn_TdjVh7pAZk8-Rq7t1hMEcuVHtY9IqPesu-bHfK_A04SWVVTFhqmzSqtW0cDPXVOHEGbymbdrD8wTcN6KwAtBFrw6VohbDl2Y5Pdymaxlo0PzE9sx-346lMJUxo9S-AJyiTNK-rIPe82F5jxxeCF_uk9m8yM08oauuSYWJZJomIddChTwEEVNwXU2ZUEGL-GNBilUN7Y4VRk5je14pwMWruBuj-MW1-LWIM-nVr6BN_kG_hjI6oUVgcnujGHTjWs_FPJQhLPqV9DR8cyQTo5lADD-uEm6YaJFFlPC4yvKdqNe4HfgsQrBLeM0zS4HgJDlGP3XlqCzjrb2jcxDtd85D9LFB9KImSgvgmZJ1WgpwHpHRGpTLDcpuhQs_jXChQQjSphrN8zi7xzwu47OpCD3Hk3V689NJMz4U4yNzU4yQBtwQRN7yWuRBpSAm4-QzLLnAgfWioToaA9lsybPPFmle-AJ-bossVUqm0WU9O2rbsR-NYs48N4Q3LE-hq2-dwD-QjwBcOvHw79-5SK5tHuzuxDtbne1H5DrDLS5XOMxfILPDwcg8JlfU12FWDp5Y_UvJp4tWUL8AG08ZEQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1fb9MwELdGhyYkxJ_xZ4XBDGLjhbDE8eoECaGOMVGNlYqxaTwFx3ZGtC0pTQviG_CZ-HTcJW4gooK97AGpUqr4nCjn853PvvsdIY9iTwqmvcTpxKbjcJ-7TqCZdmImQ86NCE1YFZsQ_X5weBgO5siPaS4MhlVOdWKpqHWucI98ncFzeCjAQ1hPbFjEYGv7xfCzgxWk8KR1Wk6jEpEd8-0ruG_F894WjPUqY9uv3r987dgKA46ChcHYiRMtpHbdONZccjBWMlQdDRYrViC33EtkgkK-oUHwYanDOsxoRHIFw-irODY-PPcCmYclOYc5Nj_o7Q4-1O5e6JY7PIiB5nhMCJu45wtv3crJ0yFYPIxTACMeNAxjWT-gthKt4UlezFoC_xnJ2cA7LW3k9tX_mbvXyBW7MqfdaipdJ3MmWyQLuzb2YJFcrnY4aZW4dYN83zvN8ZzhCZVVmWGqynTWUgfDzUxThVNq9Ix26SmeNOCOEoW1gc5PbRAVLdF9aZrR_R26mYJuzY7LnunvG7UUJjnmmpYvAHcplXQobTh8Ni5ukv1z4cst0sryzCwRuuGaRJhQJkkccC1UwAMQNwXXjYQJ1WkTfypUkbKg71h75CQqTzIFOH8VdyMUxciKYps4da9hBXryD_pNlNeaFiHLyxv56CiyGjDigQzAHVDS0_DNoYyNZgLR_biKuWGiTVZQ2qMq_7dWvFG347MQYTDhNQ9LCoQtyVBEj-SkKKLe24MzEO31z0L0rkH02BIlOfBMSZuwApxHzLQG5VqD8qhCjJ9FuNwgBGlTjeYlnOlTHhfRr2kJPacTd3bzg7oZH4qRk5nJJ0gDDgpicnltcrtSFvU4-QyLMXBgvWiokcZANluy9FOJQS98AT-3TVYrhdPospUedMuxn0wizjw3gDeszaCzt47hH8hHB5w9cefv37lCFkAvRW96_Z275BLDvS9XOMxfJq3xaGLukYvqyzgtRvetMqbk43lrqJ-pWSNg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Smoking%2C+alcohol+consumption%2C+and+cancer%3A+A+mendelian+randomisation+study+in+UK+Biobank+and+international+genetic+consortia+participants&rft.jtitle=PLoS+medicine&rft.au=Burgess%2C+Stephen&rft.au=Moyer%2C+Caitlin&rft.au=Vithayathil%2C+Mathew&rft.au=Micha%C3%ABlsson%2C+Karl&rft.date=2020-07-23&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.volume=17&rft.issue=7&rft_id=info:doi/10.1371%2Fjournal.pmed.1003178&rft.externalDBID=n%2Fa&rft.externalDocID=A632950608 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |